Status quo and future directions of digitalization in gynecology and obstetrics in Germany: a survey of the commission Digital Medicine of the German Society for Gynecology and Obstetrics
André Pfob(Heidelberg University), Peter A. Fasching(Universitätsklinikum Erlangen), Markus Wallwiener(Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie), Christoph Hillen(Universität Hamburg), Katharina Seitz(Universitätsklinikum Erlangen), Sven Becker(Goethe University Frankfurt), Uwe Wagner(German Society of Surgery), Sebastian Griewing(Philipps University of Marburg), Christian Bayer(Siemens Healthineers (Germany))
Cited by 8
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGS
|Journal of Medical Genetics|2016|217
Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers
|The American Journal of Human Genetics|2013|214